FLT3 and acute myeloid leukemia: A dose-dependent increase in apoptosis was observed in silvestrol treated compared with vehicle-treated primary blasts from FLT3-ITD (n = 3) as well as FLT3-wt (n = 2) AML patients (Figure 1e).